Candidate drug that boosts protective brain protein in mice has potential to treat Alzheimer's disease
- Details
- Category: Research
In a study published in the Nature journal npj Drug Discovery, UCLA Health researchers targeted the protein clusterin (CLU), which is crucial in preventing the build-up of amyloid-beta plaques and
Purdue center offers first comprehensive open access database of all clinically tested drugs
- Details
- Category: Development
The center, or CRIB, is a collaborative effort between Purdue and Stony Brook universities.
Diabetes drug gives hope for new treatment for prostate cancer
- Details
- Category: Research
Generative AI on track to shape the future of drug design
- Details
- Category: Research
In a new paper, Xia Ning, lead author of the study and a professor of biomedical informatics and computer science and engineering at The Ohio State University, introduces DiffSMol, a generative AI model capable of generating realistic 3D structures of small molecules that can serve as promising drug candidates.
Head-to-head trial compares weight loss drugs
- Details
- Category: Research
New research offers hope for diabetic neuropathy sufferers
- Details
- Category: Research
Findings from a new study, published in Nature Communications, suggest that cell clusters called Nageotte nodules are a strong indicator of nerve cell death in human sensory ganglia.
Drug to slow Alzheimer's well tolerated outside of clinical trial setting
- Details
- Category: Research
More Pharma News ...
- HER3 re-emerges as a pivotal target in the fight against cancer
- Mitochondrial DNA editing: A breakthrough in tackling neurodegenerative diseases
- Diabetes drug as a possible treatment for prostate cancer
- Discovery explains Long COVID breathing problems
- Harnessing generative AI to expand the mitochondrial targeting toolkit
- Shingles vaccine lowers the risk of heart disease for up to eight years
- New technology facilitates delivery of advanced medicines